Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,191
archived clinical trials in
Constipation

12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Pembroke Pines, FL
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Plant City, FL
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Plant City, FL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Plantation, FL
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Plantation, FL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Sarasota, FL
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Sarasota, FL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Seminole, FL
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Seminole, FL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Tamarac, FL
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Tamarac, FL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Tampa, FL
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Tampa, FL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Tampa, FL
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Tampa, FL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
West Palm Beach, FL
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Atlanta, GA
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Savannah, GA
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Savannah, GA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Snellville, GA
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Snellville, GA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Blackfoot, ID
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Blackfoot, ID
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Boise, ID
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Boise, ID
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Chicago, IL
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Chicago, IL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Oak Lawn, IL
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Oak Lawn, IL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Schaumburg, IL
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Schaumburg, IL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Madisonville, KY
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Madisonville, KY
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Owensboro, KY
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Owensboro, KY
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Shreveport, LA
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Shreveport, LA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Columbia, MD
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Columbia, MD
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Watertown, MA
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Watertown, MA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Buckley, MI
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Buckley, MI
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Las Vegas, NV
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Las Vegas, NV
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Newington, NH
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Newington, NH
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Blackwood, NJ
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Blackwood, NJ
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Albuquerque, NM
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Albuquerque, NM
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Albuquerque, NM
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Albuquerque, NM
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Elmsford, NY
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Elmsford, NY
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
New Hyde Park, NY
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
New York, NY
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
New York, NY
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Cary, NC
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Cary, NC
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Concord, NC
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Concord, NC
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Hickory, NC
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Hickory, NC
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
High Point, NC
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
High Point, NC
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Raleigh, NC
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Cincinnati, OH
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Cleveland, OH
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Columbus, OH
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Columbus, OH
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Kettering, OH
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Kettering, OH
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Middleburg Heights, OH
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Sylvania, OH
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Sylvania, OH
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Wadsworth, OH
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Wadsworth, OH
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Oklahoma City, OK
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Jenkintown, PA
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Jenkintown, PA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Levittown, PA
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Levittown, PA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Pittsburgh, PA
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Greer, SC
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Greer, SC
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Bristol, TN
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Bristol, TN
Click here to add this to my saved trials